9 Followers HKEX:1061 - Essex Bio-Technology Ltd Essex Bio-Technology Ltd
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 10 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

HKD 2.35    -0.01 (-0.42%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

28 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Mia Je Ngiam B.Sc.

IPO: 2001-06-27

Headquarters: HK

Employees: 1,462

Homepage

Description

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People’s Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms